Discover published sets by community

Behavioral modifications such as timed voiding and bladder training can help in managing neurogenic bladder. The intended outcome is to improve bladder function and reduce incontinence episodes.

OnabotulinumtoxinA (Botox) injections into the bladder wall help inhibit muscle contractions, preventing incontinence. The intended outcome is to improve bladder capacity and reduce episodes of urgency and frequency.

Intermittent catheterization involves the regular insertion of a catheter to drain the bladder, preventing overdistension. Intended outcome is to maintain low bladder pressures, reduce the risk of urinary tract infections (UTIs) and preserve renal function.

Neuromodulation therapy, such as sacral nerve stimulation, modulates the nerve impulses controlling the bladder to restore normal function. The intended outcome is the reduction of incontinence and improvement of urinary frequency.

Injection of bulking agents near the urethra helps in improving closure pressure. The intended outcome is to improve continence in patients with stress incontinence due to intrinsic sphincter deficiency.

Anticholinergic medications are used to relax the bladder muscles, reducing urgency and incontinence. The intended outcome is improved bladder control and decreased frequency of contractions.